P

Inventor

KAISER CARL

US51 patents
⚠️ This page may combine multiple inventors who share the name “KAISER CARL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SMITHKLINE CORP

24 patents
US4265890AMay 5, 1981

6-Phenyl thio- and 6-cyclohexyl thio-2,3,4,5-tetrahydro-1H-3-benzazepines

SMITHKLINE CORP30 citations92
US4011319AMar 8, 1977

Pharmaceutical compositions and methods involving benzazepine derivatives

SMITHKLINE CORP23 citations82
US3988339AOct 26, 1976

Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase

SMITHKLINE CORP23 citations82
US3952101AApr 20, 1976

α-Amino methyl-5-hydroxy-2-pyridinemethanols

SMITHKLINE CORP30 citations78
US4004028AJan 18, 1977

Phenoxypropanolamines

SMITHKLINE CORP17 citations74
US3976694AAug 24, 1976

α-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylphenyl ketones

SMITHKLINE CORP8 citations73
US4048229ASep 13, 1977

α-AMINOMETHYL-4-HYDROXY-3-METHYLSULFONYL BENZYL ALCOHOLS

SMITHKLINE CORP7 citations72
US3933913AJan 20, 1976

N,N'-bis[3-substituted-4-hydroxypheyl)-2-hydroxyethyl)]-polymethylenediamines

SMITHKLINE CORP15 citations72
US3985887AOct 12, 1976

3-Substituted-4-hydroxyphenyl-2-piperidylcarbinols as β-adrenergic stimulants

SMITHKLINE CORP15 citations70
US3976695AAug 24, 1976

Halogen substituted α-(aminoalkyl)-3,4-dihydroxybenzyl alcohols

SMITHKLINE CORP12 citations70
US4073912AFeb 14, 1978

Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof

SMITHKLINE CORP10 citations68
US4052506AOct 4, 1977

Pharmaceutical compositions and method of producing anti-parkinsonism activity

SMITHKLINE CORP8 citations68
US4327023AApr 27, 1982

Intermediates for preparing 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines

SMITHKLINE CORP3 citations63
US4284556AAug 18, 1981

7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines

SMITHKLINE CORP2 citations63
US3966770AJun 29, 1976

4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol

SMITHKLINE CORP2 citations62
US3939164AFeb 17, 1976

7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds

SMITHKLINE CORP5 citations62
US4024281AMay 17, 1977

N,N-bis[2-(3-substituted-4-hydroxyphenyl)-ethyl or -2-hydroxyethyl]-polymethylenediamines

SMITHKLINE CORP3 citations61
US3943173AMar 9, 1976

3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols

SMITHKLINE CORP5 citations61
US3943254AMar 9, 1976

Beta-adrenergic antagonists

SMITHKLINE CORP5 citations61
US4012528AMar 15, 1977

α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY

SMITHKLINE CORP3 citations54
US4062961ADec 13, 1977

Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase

SMITHKLINE CORP1 citations52
US3961076AJun 1, 1976

α-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylbenzyl alcohols having β-adrenergic stimulant activity

SMITHKLINE CORP0 citations52
US4013777AMar 22, 1977

Bis-phenoxypropanolamines

SMITHKLINE CORP0 citations51
US3996383ADec 7, 1976

3-Alkylamino-α-aminomethyl-4-hydroxybenzyl alcohols with β-adrenergic stimulant activity

SMITHKLINE CORP1 citations51

SMITHKLINE BECKMAN CORP

19 patents
US4760089AJul 26, 1988

Irreversible dopamine-β-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP27 citations91
US4532331AJul 30, 1985

1-Benzyl-2-aminomethyl imidazole derivatives

SMITHKLINE BECKMAN CORP23 citations82
US4719223AJan 12, 1988

Imidazolethiol dopamine-beta-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP6 citations74
US4707485ANov 17, 1987

Substituted te[1]trahydroisoquinoline derivatives having β-adrenergic receptor activity

SMITHKLINE BECKMAN CORP11 citations74
US4634711AJan 6, 1987

Pyridylalkyl imidazole-2-thiols

SMITHKLINE BECKMAN CORP10 citations74
US4529604AJul 16, 1985

N,N-Di-(n-Propyl)dopamine derivatives

SMITHKLINE BECKMAN CORP6 citations73
US4769368ASep 6, 1988

2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines

SMITHKLINE BECKMAN CORP11 citations72
US4507320AMar 26, 1985

Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine

SMITHKLINE BECKMAN CORP8 citations71
US4728741AMar 1, 1988

1-substituted-2-mercapto benzimidazole compounds and intermediates

SMITHKLINE BECKMAN CORP4 citations63
US4707488ANov 17, 1987

Dopamine-β-hydroxylase inhibitors and use thereof

SMITHKLINE BECKMAN CORP2 citations63
US4772723ASep 20, 1988

Dopamine β-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP3 citations62
US4743613AMay 10, 1988

Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity

SMITHKLINE BECKMAN CORP3 citations62
US4873357AOct 10, 1989

Trifluoro acetyl-cyano-aniline intermediates for dopamine-βhydroxylase inhibitors

SMITHKLINE BECKMAN CORP0 citations52
US4857540AAug 15, 1989

Dopamine-β-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP0 citations52
US4810811AMar 7, 1989

Dopamine-beta-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP0 citations52
US4767862AAug 30, 1988

Substituted tetrahydro isoquinoline intermediates

SMITHKLINE BECKMAN CORP0 citations52
US4761480AAug 2, 1988

P-toluene-sulfonyl-oxy substituted pyridines

SMITHKLINE BECKMAN CORP0 citations52
US4382029AMay 3, 1983

Process useful for preparing 7,8-acetamido, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines

SMITHKLINE BECKMAN CORP1 citations52
US4863944ASep 5, 1989

Dopamine-β-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP1 citations51

SCIOS NOVA INC

1 patent

MARION MERRELL DOW INC

1 patent

WOODS HOLE OCEANOGRAPHIC INST

1 patent

SMITHKLINE BEECHAM CORP

1 patent

MARION LABORATORIES INC

1 patent

SMITHKLEIN BECKMAN CORP

1 patent

SAILDRONE INC

1 patent

Showing the top 50 of 51 patents by PatentIndex Score.